Lenovo AML Risk Watch
Back to dashboard

Continental Pharma

CUST-011CustomerTier 2Medium
🇱🇧Headquarters: LebanonIndustry: HealthcareFounded: 1990Annual volume (USD): $33.6M
40
/ 100
Overall composite score
Medium

Six-dimension risk breakdown

Contributing factors
Direct Sanctions Hit
No matching entries
0
Weight 60%
Why this score: HQ jurisdiction Lebanon drives this factor: comprehensive sanctions => 100; partial => 75; no sanctions => 0.
Sources:U.S. Department of the Treasury – OFACU.S. Department of the Treasury – OFACUnited Nations Security CouncilEuropean Commission – Financial Sanctions DatabaseFinancial Action Task Force
UBO Sanctions Exposure
0 of 1 UBO(s) reside in sanctioned jurisdictions
0
Weight 30%
Why this score: Each UBO residing in a comprehensively sanctioned / FATF blacklist country contributes 60 to the score, capped at 100.
Sources:U.S. Department of the Treasury – OFACOpenSanctions e.V.
Fuzzy Watchlist Match
65% similarity to an entry on aggregated sanctions lists
65
Weight 10%
Why this score: Fuzzy name similarity against OFAC/UN/EU/OpenSanctions. Lower alone is not conclusive; this serves as an investigative trigger.
Sources:OpenSanctions e.V.U.S. Department of the Treasury – OFAC

Operating jurisdictions

  • 🇱🇧LebanonGrey
  • 🇰🇵North KoreaFATFOFAC
  • 🇰🇪KenyaGrey
  • 🇫🇮Finland
  • 🇸🇦Saudi Arabia

Subsidiaries

  • 🇦🇪Summit Fasteners (AE)
  • 🇲🇨Opal Packaging (MC)
  • 🇻🇳Northwind Electronics (VN)

Ultimate beneficial owners

  • 🇲🇽Amara HernandezPEP